| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.3892/IJO_00000542 |
| P698 | PubMed publication ID | 20126987 |
| P2093 | author name string | Yu Ren | |
| Lei Han | |||
| Xuan Zhou | |||
| Peng Xu | |||
| Chun-Sheng Kang | |||
| Chun-Zhi Zhang | |||
| Mei Mei | |||
| Pei-Yu Pu | |||
| Guang-Xiu Wang | |||
| Zhi-Fan Jia | |||
| P2860 | cites work | Human MicroRNA targets | Q21563637 |
| MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators | Q24336898 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| miRBase: tools for microRNA genomics | Q24649872 | ||
| Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway | Q24650927 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| MATCH: A tool for searching transcription factor binding sites in DNA sequences | Q24677633 | ||
| An extensive class of small RNAs in Caenorhabditis elegans | Q27860626 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| A comparison of normalization methods for high density oligonucleotide array data based on variance and bias | Q27860710 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| Extensive modulation of a set of microRNAs in primary glioblastoma | Q28263314 | ||
| The transcriptional program in the response of human fibroblasts to serum | Q28292705 | ||
| A microRNA component of the p53 tumour suppressor network | Q28305330 | ||
| Antisense and dominant-negative AKT2 cDNA inhibits glioma cell invasion | Q28569152 | ||
| TRANSFAC: transcriptional regulation, from patterns to profiles | Q29547394 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 | ||
| miR-21-mediated tumor growth | Q29616149 | ||
| MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN | Q29616575 | ||
| Global and local architecture of the mammalian microRNA-transcription factor regulatory network. | Q33290828 | ||
| Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue | Q33331288 | ||
| AKT plays a central role in tumorigenesis | Q33944165 | ||
| MYCN regulates oncogenic MicroRNAs in neuroblastoma | Q34702713 | ||
| Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer | Q34736348 | ||
| MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 | ||
| PI3K signaling and miRNA expression during the response of quiescent human fibroblasts to distinct proliferative stimuli | Q35605939 | ||
| Canalization of development by microRNAs | Q36493258 | ||
| The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention | Q36989947 | ||
| p53 enters the microRNA world | Q36998341 | ||
| Specific microRNAs modulate embryonic stem cell-derived neurogenesis. | Q37020782 | ||
| The guardian's little helper: microRNAs in the p53 tumor suppressor network | Q37023130 | ||
| MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). | Q38303663 | ||
| Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer | Q38314320 | ||
| MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas | Q40073679 | ||
| Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer | Q40134000 | ||
| Nonisotopic detection of microRNA using digoxigenin labeled RNA probes | Q40376481 | ||
| Induction of NF-kappaB by the Akt/PKB kinase | Q40950127 | ||
| Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. | Q42830960 | ||
| Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo | Q45855175 | ||
| Molecular determinants of Akt-induced keratinocyte transformation | Q46772716 | ||
| MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. | Q52582850 | ||
| The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. | Q53577688 | ||
| The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo. | Q55470672 | ||
| P433 | issue | 3 | |
| P921 | main subject | glioblastoma | Q282142 |
| microRNA expression | Q60681249 | ||
| P304 | page(s) | 665-672 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells | |
| P478 | volume | 36 |
| Q39167421 | Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA. |
| Q92879081 | Emerging role of PI3K/AKT in tumor-related epigenetic regulation |
| Q55084777 | Glioblastoma multiforme stem cells. |
| Q39221558 | MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells. |
| Q47217569 | MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway. |
| Q38497875 | MicroRNAs and cell cycle of malignant glioma |
| Q39698047 | Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. |
| Q40182494 | miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma |
Search more.